GENEVA, June 9 -- NANJING LEADS BIOLABS CO., LTD. (Building 5, 122 Huakang Road, Jiangbei New AreaNanjing, Jiangsu 210031), 南京维立志博生物科技股份有限公司 (中国江苏省南京市江北新区华康路122号加速器四期05栋) filed a patent application (PCT/CN2024/135680) for "ANTIBODY BINDING TO LILRB1/2 OR PD1-LILRB1/2 AND USE THEREOF" on Nov 29, 2024. With publication no. WO/2025/113640, the details related to the patent application was published on Jun 05, 2025.
Notably, the patent application was submitted under the Internation...